Business Daily Media

Eisai and Seikagaku Enter into Agreement for the Co-development and Marketing Alliance of SI-613, a Treatment of Osteoarthritis, in China

  • Written by ACN Newswire - Press Releases

image

TOKYO, Apr 1, 2020 - (JCN Newswire) - Eisai Co., Ltd. and Seikagaku announced today that the companies have entered into an agreement for the co-development and marketing alliance in China for SI-613 (diclofenac conjugated sodium hyaluronate), a therapeutic agent for osteoarthritis discovered by Seikagaku.

On the basis of this agreement, the

Read more //?#

6 ways to save electricity while working from home during COVID-19

With many Aussies now working from home due to Government-mandated restrictions, there may be concerns that staying home could be driving up energy ...

Business Training

Why do you need to take care of your WordPress website?

Maintaining a WordPress website is essential for ensuring that it runs smoothly and looks professional. Not keeping your website in good health can ...

Business Training

Sydney Rain Bombs Could Be On The Increase

Motorway closures, forced evacuations, and flooding – Sydney has seen it all, including the recent weather event that has been dubbed the Taylor Swi...

Property

Strengthening information security: A vital step forward for businesses in wake of cyber attacks

In an era where cybercrime is on the rise, businesses are facing an unprecedented threat to their clients' private information. As the Australi...

Business Training

5 Steps for Creating Effective Solutions to UX Problems

One of the most important components of any website or app is the design of the user experience (UX). Even the smallest UX issues need to be ident...

Business Training

iPhone Security Issues: How you can Secure your Device

A common belief is that iPhones are much more secure than Android devices. The truth, however, is that iPhone vulnerabilities exist and are not ne...

Business Training